Ledger.Open graph →

SEC Form D · Amendment · filed December 17, 2021

Bryn Pharma, LLC

Offering

$30.0M

Sold

$28.3M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

RALEIGH, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Michelle Lobel · Raleigh, NCExec · Director David Dworaczyk · Raleigh, NCExec · Director Steven Hartman · Raleigh, NCExec · Director Katherine Grell · Raleigh, NCDirector Robert Yanez · Raleigh, NCExec Martin Devenport · Rockville, MDExec · Director Heather Raines · Knoxville, TNDirector Tremblant Capital LP · Stamford, CTExec Kun-Liang Guan · Rockville, MDExec · Director Rajul Garg · Singapore, U0Exec · Director Swan E. Sit · EMERYVILLE, CAExec · Director Xiaopei (Ray) Wang · EMERYVILLE, CAExec · Director Andrew M. Jones · EMERYVILLE, CAExec · Director Travis M. Joyner · Hamilton, MTDirector Mike Palm · Grand Rapids, MIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗